Maura Campbell

      President and CEO, Ontario Bioscience Innovation Organization

      Currently the President and CEO of the Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, I have over 30 years of leadership experience in managing successful companies in all key sectors of biotech, including private and public companies, universities and research institutes, and government-funded public sector research organizations.

      Prior to assuming the leadership of OBIO®, I was the organization’s Chair of the Board of Directors from November 25, 2019 to February 1, 2022.

      As a strategic thinker with expertise in technology transfer and commercialization of intellectual property, I have held various roles in senior management over the years. Most recently, I was the Vice-President of Intellectual Property and Contracts for Turnstone Biologics and played a crucial role in the company’s seed, and Series A, B, C, and D financing, in addition to executing two large pharma-licensing deals, raising over US $370 million for Turnstone in six years since the company’s inception in 2015. Previously, I served as Director, Intellectual Property at VBI Vaccines.

      Among the various roles I held in my career are Senior Research Program Manager, and Manager of Technology Transfer & Commercialization at the Ottawa Hospital Research Institute, Director of Intellectual Property for PainCeptor Pharma Corporation, and Manager of Technology Transfer at the Institute for Robotics and Intelligent Systems National Centre of Excellence.

      I hold a Ph.D. in biochemistry from the University of Ottawa, and an M.Sc. and a B.Sc. in biochemistry from Queen’s University in Kingston.

      Maura Campbell

      Maura Campbell

      President and CEO, Ontario Bioscience Innovation Organization

      Contact information